在透析乳腺癌患者的全身瘤治疗
Salman Khan1, Ghada Araji2, Ekrem Yetiskul2
1Department of Internal Medicine, Northwell Health - Staten Island University Hospital, Staten Island, NY 10305, United States. skhan114@northwell.edu.
World journal of clinical oncology
|July 1, 2024
概括
在透析中患有末期病 (ESRD) 的患者患癌症的风险增加. 本综述强调了优化透析患者乳腺癌治疗的挑战和策略,重点关注药物剂量和查.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 改善的替代疗法 (RRT) 增加了末期病 (ESRD) 患者的存活率.
- 在ESRD患者中,延长生存时间与癌症发病率较高有关,包括乳腺癌.
- 标准乳腺癌治疗在接受透析的ESRD患者中面临复杂性.
研究的目的:
- 审查乳腺癌查和诊断对透析患者的挑战.
- 强调需要优化乳腺癌ESRD患者的全身疗法剂量和管理.
- 确保乳腺癌治疗在置换疗法的背景下有效和安全.
主要方法:
- 文献综述侧重于透析ESRD患者的乳腺癌治疗.
- 分析药物清除,剂量和系统疗法的管理方面的挑战.
- 检查查和诊断障碍,包括成像器件的检查.
主要成果:
- 透析患者的药物药理动力学变化需要量身定制的全身治疗方案.
- 乳腺癌查可能因ESRD中常见的软组织化而复杂.
- 优化剂量和施用时间表对于透析患者的乳腺癌管理至关重要.
结论:
- 在ESRD患者中有效的乳腺癌管理需要仔细考虑RRT状态.
- 需要进一步的研究,以建立基于证据的指导方针,在这个人群中进行全身疗法.
- 多学科方法对于改善乳腺癌透析患者的治疗结果至关重要.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510


